These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22569635)

  • 1. Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris.
    Choi BK; Warburton S; Lin H; Patel R; Boldogh I; Meehl M; d'Anjou M; Pon L; Stadheim TA; Sethuraman N
    Appl Microbiol Biotechnol; 2012 Aug; 95(3):671-82. PubMed ID: 22569635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The yeast oligosaccharyltransferase complex can be replaced by STT3 from Leishmania major.
    Hese K; Otto C; Routier FH; Lehle L
    Glycobiology; 2009 Feb; 19(2):160-71. PubMed ID: 18955371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An oligosaccharyltransferase from Leishmania major increases the N-glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana.
    Castilho A; Beihammer G; Pfeiffer C; Göritzer K; Montero-Morales L; Vavra U; Maresch D; Grünwald-Gruber C; Altmann F; Steinkellner H; Strasser R
    Plant Biotechnol J; 2018 Oct; 16(10):1700-1709. PubMed ID: 29479800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of N-linked glycosylation on recombinant glycoproteins produced in Pichia pastoris using ESI-MS and MALDI-TOF.
    Gong B; Cukan M; Fisher R; Li H; Stadheim TA; Gerngross T
    Methods Mol Biol; 2009; 534():213-23. PubMed ID: 19277549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry.
    Gong B; Burnina I; Stadheim TA; Li H
    J Mass Spectrom; 2013 Dec; 48(12):1308-17. PubMed ID: 24338886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N- and O-linked carbohydrates and glycosylation site occupancy in recombinant human granulocyte-macrophage colony-stimulating factor secreted by a Chinese hamster ovary cell line.
    Forno G; Bollati Fogolin M; Oggero M; Kratje R; Etcheverrigaray M; Conradt HS; Nimtz M
    Eur J Biochem; 2004 Mar; 271(5):907-19. PubMed ID: 15009203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pichia pastoris versus Saccharomyces cerevisiae: a case study on the recombinant production of human granulocyte-macrophage colony-stimulating factor.
    Tran AM; Nguyen TT; Nguyen CT; Huynh-Thi XM; Nguyen CT; Trinh MT; Tran LT; Cartwright SP; Bill RM; Tran-Van H
    BMC Res Notes; 2017 Apr; 10(1):148. PubMed ID: 28376863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.
    Choi BK; Actor JK; Rios S; d'Anjou M; Stadheim TA; Warburton S; Giaccone E; Cukan M; Li H; Kull A; Sharkey N; Gollnick P; Kocieba M; Artym J; Zimecki M; Kruzel ML; Wildt S
    Glycoconj J; 2008 Aug; 25(6):581-93. PubMed ID: 18365311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of a glycoengineered Pichia pastoris cultivation process for commercial antibody production.
    Ye J; Ly J; Watts K; Hsu A; Walker A; McLaughlin K; Berdichevsky M; Prinz B; Sean Kersey D; d'Anjou M; Pollard D; Potgieter T
    Biotechnol Prog; 2011; 27(6):1744-50. PubMed ID: 22002933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose.
    Bobrowicz P; Davidson RC; Li H; Potgieter TI; Nett JH; Hamilton SR; Stadheim TA; Miele RG; Bobrowicz B; Mitchell T; Rausch S; Renfer E; Wildt S
    Glycobiology; 2004 Sep; 14(9):757-66. PubMed ID: 15190003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-glycosylation and homodimeric folding significantly enhance the immunoreactivity of Mycobacterium tuberculosis virulence factor CFP32 when produced in the yeast Pichia pastoris.
    Benabdessalem C; Othman H; Ouni R; Ghouibi N; Dahman A; Riahi R; Larguach B; Jihene Bettaieb ; Srairi-Abid N; Barbouche MR; Fathallah MD
    Biochem Biophys Res Commun; 2019 Aug; 516(3):845-850. PubMed ID: 31262446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of yeast Pichia pastoris to produce Man5GlcNAc2 mammalian mannose-type glycoprotein].
    Yang X; Liu B; Song M; Gong X; Chang S; Xue K; Wu J
    Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):108-17. PubMed ID: 21553496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cell culture conditions to control N-glycosylation site-occupancy of recombinant glycoproteins expressed in CHO cells.
    Gawlitzek M; Estacio M; Fürch T; Kiss R
    Biotechnol Bioeng; 2009 Aug; 103(6):1164-75. PubMed ID: 19418565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homogeneous production and characterization of recombinant N-GlcNAc-protein in Pichia pastoris.
    Wang S; Rong Y; Wang Y; Kong D; Wang PG; Chen M; Kong Y
    Microb Cell Fact; 2020 Jan; 19(1):7. PubMed ID: 31931833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Methanol-Free Platform for Extracellular Expression of rhGM-CSF in Pichia pastoris.
    Shirvani R; Yazdanpanah S; Barshan-Tashnizi M; Shahali M
    Mol Biotechnol; 2019 Jul; 61(7):521-527. PubMed ID: 31054084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-linked glycosylation analysis of recombinant human granulocyte colony-stimulating factor produced in glycoengineered Pichia pastoris by liquid chromatography and mass spectrometry.
    Gong B; Burnina I; Lynaugh H; Li H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():135-40. PubMed ID: 24334224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over expression and analysis of O-glycosylated recombinant human granulocyte colony stimulating factor in Pichia pastoris using Agilent 2100 Bioanalyzer.
    Apte-Deshpande A; Somani S; Mandal G; Soorapaneni S; Padmanabhan S
    J Biotechnol; 2009 Aug; 143(1):44-50. PubMed ID: 19527756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris.
    Ha S; Wang Y; Rustandi RR
    MAbs; 2011; 3(5):453-60. PubMed ID: 22048694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet-Derived Growth Factor-BB in Pichia pastoris.
    Dai M; Yu C; Fang T; Fu L; Wang J; Zhang J; Ren J; Xu J; Zhang X; Chen W
    PLoS One; 2015; 10(12):e0145419. PubMed ID: 26701617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris.
    Gomathinayagam S; Laface D; Houston-Cummings NR; Mangadu R; Moore R; Shandil I; Sharkey N; Li H; Stadheim TA; Zha D
    J Biotechnol; 2015 Aug; 208():13-21. PubMed ID: 26015261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.